This study is in progress, not accepting new patients
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Priscilla Hsue, MD (ucsf)Annie Leutkemeyer (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientists at UC Health
- Priscilla Hsue, MD (ucsf)
Professional Experience: Dr. Hsue trained in Internal Medicine in the Molecular Medicine Training Program at UC San Francisco and in Cardiovascular Medicine at UC San Francisco. She served as Chief Cardiology Fellow during this time. She has been on the faculty in the Department of Medicine at San Francisco General Hospital since 2002. - Annie Leutkemeyer (ucsf)
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Priscilla Hsue, MD
- ID
- NCT04421404
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated